Menu

J. Evrard

Articles

P23 BETRIXABAN: IMPACT ON ROUTINE AND SPECIFIC COAGULATION ASSAYS – A PRACTICAL LABORATORY GUIDE

BJH - 2019, issue ?, february 2019

R. Siriez , J. Evrard , J-M. Dogné PhD, PharmD, L. Pochet , F. Mullier PhD, PharmD, J. Douxfils PhD, PharmD

Read more

P24 IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA

BJH - 2019, issue ?, february 2019

R. Siriez , J. Evrard , J-M. Dogné PhD, PharmD, L. Pochet , C. Bouvy , S. Lessire , F. Mullier PhD, PharmD, J. Douxfils PhD, PharmD

Read more

P25 CLOT WAVEFORM ANALYSIS: DETERMINATION OF OPTIMAL WAVELENGTH TO ASSESS THE FIBRIN COAGULATION PROCESS

BJH - 2019, issue ?, february 2019

J. Evrard , R. Siriez , L. Morimont , F. Mullier PhD, PharmD, J-M. Dogné PhD, PharmD, J. Douxfils PhD, PharmD

Read more

P26 ASSESSMENT OF INNER-FILTER OF THE REAGENTS OF THE COAGULATION PATHWAY ON BASELINE ABSORBANCE IN CLOT WAVEFORM ANALYSIS

BJH - 2019, issue ?, february 2019

J. Evrard , R. Siriez , L. Morimont , F. Mullier PhD, PharmD, J-M. Dogné PhD, PharmD, J. Douxfils PhD, PharmD

Read more

PP47 mBetrixaban: Impact on routine and specific coagulation assays – A practical laboratory guide

BJH - 2018, issue Abstract Book BHS, february 2018

R. Siriez , J. Evrard , J-M. Dogné PhD, PharmD, L. Pochet , D. Gheldof , B. Chatelain PharmD, C. Vancraeynest , P. Devel , M. Guldenpfennig , C. Devroye , F. Mullier PhD, PharmD, J. Douxfils PhD, PharmD

Read more
Top